Incyte Common Stock Total Equity from 2010 to 2024

INCY Stock  USD 53.76  0.67  1.26%   
Incyte Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity will likely drop to about 154 K in 2024. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2000-03-31
Previous Quarter
223 K
Current Value
223 K
Quarterly Volatility
60.5 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many exotic indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
  
This module can also supplement Incyte's financial leverage analysis and stock options assessment as well as various Incyte Technical models . Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Latest Incyte's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Incyte over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Incyte's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Incyte Common Stock Total Equity Regression Statistics

Arithmetic Mean183,230
Geometric Mean175,227
Coefficient Of Variation26.65
Mean Deviation38,184
Median189,000
Standard Deviation48,831
Sample Variance2.4B
Range190.4K
R-Value0.75
Mean Square Error1.1B
R-Squared0.57
Significance0
Slope8,238
Total Sum of Squares33.4B

Incyte Common Stock Total Equity History

2024154 K
2023256.4 K
2022223 K
2021221 K
2020219 K
2019216 K
2018213 K

About Incyte Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Incyte income statement, its balance sheet, and the statement of cash flows. Incyte investors use historical funamental indicators, such as Incyte's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Incyte investors may use each financial statement separately, they are all related. The changes in Incyte's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Incyte's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Incyte Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Incyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity256.4 K154 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:
Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
6.705
Earnings Share
3.3
Revenue Per Share
16.82
Quarterly Revenue Growth
0.089
Return On Assets
0.0689
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.